<p>Pimecrolimus Cream is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate&nbsp;atopic dermatitis&nbsp;in non-immunocompromised&nbsp;adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable.<br />
<br />
Pimecrolimus Cream is not indicated for use in children less than 2 years of age.</p>